Histone H3.1 Peptide, aa 105-124 Peptide, Biotinylated Description:A synthetic peptide derived from human histone H3, amino acids 105-124. The alpha-amino group on the N-terminus is acetylated, there is a PEG spacer, an added lysine residue containing a biotin moiety at the epsilon amino group, and a C-terminal amide group (NH2).
|
Histone H3.1 Peptide, aa 105-124 Peptide, Biotinylated, Formulation:
50 µg of lyophilized powder.
|
Histone H3.1 Peptide, aa 105-124 Peptide, Biotinylated Sequence:
Ac-EDTNLCAIHAKRVTIMPKDI-PEG-K(Biot)-NH2
|
Molec. Weight: 2966.5 Da
|
Purity: >99% as judged by HPLC and mass spectrometry.
|
Storage and Stability: Lyophilized peptides are stable for 2 years at -20°C from date of shipment. Peptides in solution are stable for 6 months at -80°C. Spin vial briefly in microfuge and reconstitute with sterile distilled water and vortex briefly until resuspended. Aliquot peptide to avoid repeated freezing and thawing.
|
| Quality Control: Peptide purified by reversed-phase HPLC and analyzed using MALDI-TOF mass spectrometry and analytical RP-HPLC.
|
|
Mass Spec Data: MALDI-TOF mass spectrometry was used to analyze Histone H3.1 Peptide, aa 105-124 Peptide, for identity and homogeneity.
|
HPLC Data: Reversed phase analytical HPLC chromatogram of purified Histone H3.1 Peptide, aa 105-124 Peptide.
|
|
